These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Angiotensin II modulates VEGF-driven angiogenesis by opposing effects of type 1 and type 2 receptor stimulation in the microvascular endothelium. Carbajo-Lozoya J; Lutz S; Feng Y; Kroll J; Hammes HP; Wieland T Cell Signal; 2012 Jun; 24(6):1261-9. PubMed ID: 22374305 [TBL] [Abstract][Full Text] [Related]
4. Baicalin reduces the permeability of the blood-brain barrier during hypoxia in vitro by increasing the expression of tight junction proteins in brain microvascular endothelial cells. Zhu H; Wang Z; Xing Y; Gao Y; Ma T; Lou L; Lou J; Gao Y; Wang S; Wang Y J Ethnopharmacol; 2012 Jun; 141(2):714-20. PubMed ID: 21920425 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin II impairs endothelial progenitor cell number and function in vitro and in vivo: implications for vascular regeneration. Endtmann C; Ebrahimian T; Czech T; Arfa O; Laufs U; Fritz M; Wassmann K; Werner N; Petoumenos V; Nickenig G; Wassmann S Hypertension; 2011 Sep; 58(3):394-403. PubMed ID: 21825227 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin II induced cerebral microvascular inflammation and increased blood-brain barrier permeability via oxidative stress. Zhang M; Mao Y; Ramirez SH; Tuma RF; Chabrashvili T Neuroscience; 2010 Dec; 171(3):852-8. PubMed ID: 20870012 [TBL] [Abstract][Full Text] [Related]
7. AT1 receptor antagonist telmisartan administered peripherally inhibits central responses to angiotensin II in conscious rats. Gohlke P; Weiss S; Jansen A; Wienen W; Stangier J; Rascher W; Culman J; Unger T J Pharmacol Exp Ther; 2001 Jul; 298(1):62-70. PubMed ID: 11408526 [TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor-γ activation with angiotensin II type 1 receptor blockade is pivotal for the prevention of blood-brain barrier impairment and cognitive decline in type 2 diabetic mice. Min LJ; Mogi M; Shudou M; Jing F; Tsukuda K; Ohshima K; Iwanami J; Horiuchi M Hypertension; 2012 May; 59(5):1079-88. PubMed ID: 22454480 [TBL] [Abstract][Full Text] [Related]
9. Role of AT1 receptors in permeability of the blood-brain barrier in diabetic hypertensive rats. Awad AS Vascul Pharmacol; 2006 Sep; 45(3):141-7. PubMed ID: 16959546 [TBL] [Abstract][Full Text] [Related]
10. Angiotensin II type 1 receptor activation increases microvascular hydraulic permeability. Newton CR; Curran B; Victorino GP Surgery; 2004 Nov; 136(5):1054-60. PubMed ID: 15523401 [TBL] [Abstract][Full Text] [Related]
11. Angiotensin II upregulates acyl-CoA:cholesterol acyltransferase-1 via the angiotensin II Type 1 receptor in human monocyte-macrophages. Kanome T; Watanabe T; Nishio K; Takahashi K; Hongo S; Miyazaki A Hypertens Res; 2008 Sep; 31(9):1801-10. PubMed ID: 18971559 [TBL] [Abstract][Full Text] [Related]
12. AT(1) receptor blockers increase insulin-like growth factor-I production by stimulating sensory neurons in spontaneously hypertensive rats. Harada N; Shimozawa N; Okajima K Transl Res; 2009 Sep; 154(3):142-52. PubMed ID: 19665690 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin type 1 receptor is linked to inhibition of nitric oxide production in pulmonary endothelial cells. Zhao X; Li X; Trusa S; Olson SC Regul Pept; 2005 Dec; 132(1-3):113-22. PubMed ID: 16242794 [TBL] [Abstract][Full Text] [Related]
14. Synergistic effect of angiotensin II on vascular endothelial growth factor-A-mediated differentiation of bone marrow-derived mesenchymal stem cells into endothelial cells. Ikhapoh IA; Pelham CJ; Agrawal DK Stem Cell Res Ther; 2015 Jan; 6(1):4. PubMed ID: 25563650 [TBL] [Abstract][Full Text] [Related]
15. Angiotensin II-induced stimulation of collagen secretion and production in cardiac fibroblasts is mediated via angiotensin II subtype 1 receptors. Lijnen PJ; Petrov VV; Fagard RH J Renin Angiotensin Aldosterone Syst; 2001 Jun; 2(2):117-22. PubMed ID: 11881110 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin II stimulates MCP-1 production in rat glomerular endothelial cells via NAD(P)H oxidase-dependent nuclear factor-kappa B signaling. Pan Q; Yang XH; Cheng YX Braz J Med Biol Res; 2009 Jun; 42(6):531-6. PubMed ID: 19448902 [TBL] [Abstract][Full Text] [Related]
17. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension. Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC J Hypertens; 2010 Jan; 28(1):111-8. PubMed ID: 19797979 [TBL] [Abstract][Full Text] [Related]
18. LPS induces permeability injury in lung microvascular endothelium via AT(1) receptor. Zhang H; Sun GY Arch Biochem Biophys; 2005 Sep; 441(1):75-83. PubMed ID: 16098473 [TBL] [Abstract][Full Text] [Related]
19. Effects of methyl-beta-cyclodextrin on blood-brain barrier permeability in angiotensin II-induced hypertensive rats. Atış M; Akcan U; Uğur Yılmaz C; Orhan N; Düzgün P; Deniz Ceylan U; Arıcan N; Karahüseyinoğlu S; Nur Şahin G; Ahıshalı B; Kaya M Brain Res; 2019 Jul; 1715():148-155. PubMed ID: 30914250 [TBL] [Abstract][Full Text] [Related]
20. Telmisartan inhibits vasoconstriction via PPARγ-dependent expression and activation of endothelial nitric oxide synthase. Yuen CY; Wong WT; Tian XY; Wong SL; Lau CW; Yu J; Tomlinson B; Yao X; Huang Y Cardiovasc Res; 2011 Apr; 90(1):122-9. PubMed ID: 21156825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]